403
Views
5
CrossRef citations to date
0
Altmetric
Review

Drug discovery strategies for novel leukotriene A4 hydrolase inhibitors

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1483-1495 | Received 30 Apr 2021, Accepted 24 Jun 2021, Published online: 16 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sinan Wu, Ke Huang, Chenli Chang, Xu Chu, Kun Zhang, Baicun Li & Ting Yang. (2023) Serum Proteomic Profiling in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1623-1635.
Read now
Wei Chen, Chunyu Li, Dujia Jin, Yafei Shi, Mingyu Zhang, Mingming Bo, Di Qian, Mengyang Wang & Guohui Li. (2022) Metabolomics Combined with Network Pharmacology-Based Strategy to Reveal the Underlying Mechanism of Zhenhuang Submicron Emulsion in Treating Oropharyngeal Mucositis Complications of Radiation Therapy for Head and Neck Cancer. Drug Design, Development and Therapy 16, pages 3169-3182.
Read now

Articles from other publishers (3)

Jesper Z. HaeggströmMarcia E. Newcomer. (2023) Structures of Leukotriene Biosynthetic Enzymes and Development of New Therapeutics. Annual Review of Pharmacology and Toxicology 63:1, pages 407-428.
Crossref
Birk Poller, David Pearson, Luc Alexis Leuthold, Martin Fink, Astrid Jullion, Patrick Schweigler, Ester Tor Carreras, Cyrille Marvalin, Christian Loesche & H. Markus Weiss. (2022) Human Pharmacokinetics of LYS006, an Oral Leukotriene A4 Hydrolase Inhibitor Displaying Target-Mediated Drug Disposition. Drug Metabolism and Disposition 50:12, pages 1472-1482.
Crossref
Carla S. S. Teixeira & Sérgio F. Sousa. (2021) Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets. Pharmaceutics 14:1, pages 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.